12 results match your criteria: "North East Cancer Center[Affiliation]"
What Is Ailing Oncology Clinical Trials? Can We Fix Them?
Curr Oncol
June 2024
Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON K1H8L6, Canada.
Evidence from phase three clinical trials helps shape clinical practice. However, a very small minority of patients with cancer participate in clinical trials and many trials are not completed on time due to slow accrual. Issues with restrictive eligibility criteria can severely limit the patients who can access trials, without any convincing evidence that these restrictions impact patient safety.
View Article and Find Full Text PDFCorrection to: Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and Clinical Practice Guidelines - Part 1: vitamins, minerals and nutritional supplements.
Support Care Cancer
July 2021
Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA.
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Cancer
October 2020
Medical Oncology Department, University of Brescia, Brescia, Italy.
Background: Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis.
Methods: The literature was reviewed systematically to identify interventions for mucositis.
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents.
Support Care Cancer
May 2020
University of Rochester Medical Center Oral Medicine, Eastman Institute for Oral Health Rochester, New York, USA.
Objective: To update the clinical practice guidelines for the management of oral mucositis (OM) that were developed by the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). This part focuses on honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents.
Methods: A systematic review was conducted by the Mucositis Study Group of MASCC/ISOO.
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines.
Support Care Cancer
May 2020
Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA.
Purpose: To update the clinical practice guidelines for the use of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the prevention and/or treatment of oral mucositis (OM).
Methods: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). The body of evidence for each intervention, in each cancer treatment setting, was assigned an evidence level.
Reply to Fusco et al.
JCO Oncol Pract
March 2020
Noam Yarom, DMD, Sheba Medical Center, Tel Hashomer, and Tel Aviv University, Tel Aviv, Israel; Douglas E. Peterson, DMD, PhD, School of Dental Medicine and Neag Comprehensive Cancer Center, UConn Health, Farmington, CT; Kari Bohlke, ScD, American Society of Clinical Oncology, Alexandria, VA; and Deborah P. Saunders, BSc, DMD, North East Cancer Center, Health Sciences North, Northern Ontario School of Medicine, Sudbury, Ontario, Canada.
Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines.
Support Care Cancer
May 2020
Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA.
Purpose: To update the 2013 Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) clinical practice guidelines on oral cryotherapy for the management of oral mucositis (OM) caused by cancer therapies.
Methods: A systematic review was conducted by the Mucositis Study Group of MASCC/ISOO. The evidence for each intervention for specific cancer treatment modalities was assigned a level of evidence (LoE).
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements.
Support Care Cancer
October 2019
Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA.
Purpose: To update the clinical practice guidelines for the use of natural and miscellaneous agents for the prevention and/or treatment of oral mucositis (OM).
Methods: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO). The body of evidence for each intervention, in each cancer treatment setting, was assigned an evidence level.
A systematic review of dental disease management in cancer patients.
Support Care Cancer
January 2018
Dental Oncology Program, Health Sciences North, North East Cancer Center, 41 Ramsey Lake Road, Sudbury, ON, P3E 5J1, Canada.
Introduction: This systematic review aims to update on the prevalence of odontogenic-related infections and the efficacy of dental strategies in preventing dental-related complications in cancer patients since the 2010 systematic review.
Review Method: A literature search was conducted in the databases MEDLINE/PubMed and EMBASE for articles published between 1 January 2009 and 30 June 2016. Each study was assessed by 2 reviewers and the body of evidence for each intervention was assigned an evidence level.
A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.
Support Care Cancer
February 2017
Department of Dentistry and Oral Health, Faculty of Health, Aarhus University, Aarhus C, Denmark.
Purpose: To review the literature for outcome measures for oral viral infections in cancer patients. A secondary aim was to update the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) clinical practice guidelines for the management of oral viral infections in cancer patients.
Methods: Databases were searched for articles published in the English language, 1981-2013.
Erratum to: Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.
Support Care Cancer
February 2015
Department of Dental Oncology, North East Cancer Center, Health Sciences North, Sudbury, Ontario, Canada,
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.
Support Care Cancer
November 2013
Department of Dental Oncology, North East Cancer Center, Health Sciences North, Sudbury, Ontario, Canada,
Purpose: The aim of this project was to develop clinical practice guidelines on the use of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the prevention and management of oral mucositis (OM) in cancer patients.
Methods: A systematic review of the available literature was conducted. The body of evidence for the use of each agent, in each setting, was assigned a level of evidence.